磁共振引导聚焦超声治疗骨样骨瘤的疗效与安全性:系统综述与Meta分析
该系统综述与Meta分析共纳入2012至2022年间发表的113项研究、353例患者,评估MRgFUS治疗骨样骨瘤的疗效与安全性。治疗后1周和1个月疼痛评分分别为0.62(95%CI 0.28-0.96)和0.37(95%CI 0.07-0.68),成功率为92.8%(95%CI 89.8%-95.7%),轻微并发症(消融部位热损伤)发生率为0.85%,未记录到重大并发症。结论认为MRgFUS是治疗骨样骨瘤疼痛的有效方法,疗效和安全性令人满意。
要点
- MRgFUS治疗后1周疼痛评分为0.62(95%CI 0.28-0.96),1个月为0.37(95%CI 0.07-0.68)。
- 完全疼痛缓解且至末次随访无复发的成功率为92.8%(95%CI 89.8%-95.7%)。
- 轻微并发症(消融部位热损伤)发生率为0.85%,纳入文献均未记录重大并发症。
核心结论
- MRgFUS是治疗骨样骨瘤疼痛的有效方法,疗效和安全性令人满意。
研究设计与样本
- 系统综述与Meta分析,共纳入2012至2022年间发表的113项研究、总样本量353例患者;多数研究为前瞻性,随访时间4周或以上,总体证据质量从低到高不等;检索PubMed、Embase、Web of Science和Cochrane Library数据库。
诊断标准与关键数值
- 治疗后1周疼痛评分为0.62(95%CI 0.28-0.96),1个月为0.37(95%CI 0.07-0.68);成功率为92.8%(95%CI 89.8%-95.7%),成功定义为完全疼痛缓解且至末次随访无复发;轻微并发症(消融部位热损伤)发生率为0.85%,未记录重大并发症。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: Magnetic resonance-guided focused ultrasound (MRgFUS) is a novel noninvasive interventional technique for osteoid osteoma (OO). The purpose of this study was to evaluate the efficacy and safety of MRgFUS in the treatment of OO through a systematic review and meta-analysis of pain scores and post-treatment adverse events before and after MRgFUS treatment.
MATERIALS AND METHODS: A comprehensive literature search of PubMed, Embase, Web of science, and Cochrane Library databases was conducted to screen the study literature based on inclusion and exclusion criteria to extract and analyze pre- and post-treatment pain score data, success rates (complete pain relief with no recurrence until the last follow-up), recurrence rates, secondary intervention rates, and complications to evaluate the efficacy and/or safety of MRgFUS for OO.
RESULTS: A total of 113 studies published between 2012 and 2022were collected, resulting in a total sample size of 353 patients. The majority of the studies were prospective and had a follow-up period of 4 weeks or more, and overall, the quality of evidence ranged from low to high. Pain scores at 1 week and 1 month after the merger were 0.62 (9.5% CI:0.28-0.96) and 0.37 (9.5% CI:0.07-0.68), respectively. The success rate of the combination was 92.8% (95% CI: 89.8%-95.7%), the incidence of minor complications (thermal injury at the ablation site) was 0.85%, and no major complications were recorded in any of the included literature.
CONCLUSION: MRgFUS is an effective procedure that is able to treat pain for patients with OO with satisfying efficacy and safety.
PROSPERO: No.CRD42023415573.
引用
- Hu R, He P, Tian X, et al. Efficacy and safety of magnetic resonance-guided focused ultrasound for the treatment of osteoid osteoma: A systematic review and meta-analysis. Eur J Radiol. 2023. PMID: 37523874. doi:10.1016/j.ejrad.2023.111006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。